Mitsubishi Chemical raises UK SoarnoL investment amid delays, inflation, and higher costs, while maintaining long-term growth and sustainability commitment strategy.
Mitsubishi Chemical Group Corporation has announced a significant revision to its investment strategy in the United Kingdom for its SoarnoL ethylene-vinyl alcohol (EVOH) resin business, reflecting escalating costs and mounting execution challenges at its expansion facility in Hull. The decision comes as the company navigates a combination of construction delays, technical complexities, and broader inflationary pressures that have reshaped the financial outlook of the project.
Under the leadership of President and CEO Manabu Chikumoto, the group confirmed that the revised plan directly impacts its subsidiary, Mitsubishi Chemical UK Limited, which is responsible for the production and commercialization of SoarnoL. This specialized resin, developed using proprietary technology, is widely recognized for its excellent gas barrier properties, resistance to oils, and high transparency. It plays a crucial role in food packaging applications by extending shelf life, minimizing spoilage, and helping reduce food waste. Additionally, its ability to maintain performance even in thinner layers contributes to lowering overall plastic consumption, aligning with sustainability goals.
Initially, the Hull expansion project was designed to increase SoarnoL’s annual production capacity by approximately 21,000 tons. However, the company has encountered a series of structural and operational hurdles. These include inconsistent construction progress, increasingly complex contracting arrangements, and the need for enhanced safety evaluations. Such issues have slowed progress across various phases of development, prompting a reassessment of both timelines and budgets.
Further complicating the situation, updated engineering designs and on-site cost evaluations revealed that construction expenses would be substantially higher than initially anticipated. The company also highlighted the impact of global inflation, which has driven up the costs of raw materials and labor, further straining the project’s financial framework.
As a consequence, Mitsubishi Chemical Group has been compelled to increase its total investment in the UK facility, a move that is expected to weigh on profitability. The timeline for project completion has also been extended, with the new plant now slated to commence operations in fiscal year 2027.
In terms of financial impact, the company disclosed that it expects to record an impairment loss of around 30 billion yen for the fiscal year ending March 31, 2026. This charge is associated with SoarnoL-related fixed assets as well as prior capital expenditures tied to the project. Notably, this impairment was not included in the earnings forecast released earlier on February 5, 2026. As a result, Mitsubishi Chemical Group is currently reviewing its full-year consolidated financial results and may revise its guidance depending on further developments.
Despite these setbacks, the company remains committed to SoarnoL as a key pillar of its long-term growth strategy under the KAITEKI Vision 35 framework. This strategic vision emphasizes sustainable solutions, particularly in areas such as food quality preservation. Mitsubishi Chemical Group reiterated that SoarnoL continues to be central to its Chemicals Business segment and affirmed its intention to keep investing in advanced materials that contribute to both sustainability and improved food systems.
The revised investment outlook comes amid a mixed financial performance. The company has forecast sales revenue of 3,672,000 million yen for fiscal 2026, down from 3,947,566 million yen in the previous year. However, net income attributable to shareholders is projected to reach 47,000 million yen, slightly higher than the 45,020 million yen recorded a year earlier.
